{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T17:40:04Z","timestamp":1776966004054,"version":"3.51.4"},"reference-count":0,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"am","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Lay Summary<\/jats:title>\n                  <jats:p>A retrospective study showed that, over three or more years, few ulcerative colitis patients stay on long-term, steroid-free advanced treatment, revealing a need for additional treatment options that can sustain remission.<\/jats:p>","DOI":"10.1093\/crocol\/otag035","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T11:14:08Z","timestamp":1776510848000},"source":"Crossref","is-referenced-by-count":0,"title":["Advanced Therapy Treatment Patterns in Moderate-to-Severe Ulcerative Colitis: A Long-Term Retrospective Claims Analysis"],"prefix":"10.1093","author":[{"given":"Parambir S","family":"Dulai","sequence":"first","affiliation":[{"name":"Northwestern University Division of Gastroenterology and Hepatology, Feinberg School of Medicine, , Chicago, IL"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher J","family":"Rabbat","sequence":"additional","affiliation":[{"name":"Abivax , Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Nason","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc , ., New York, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yechu","family":"Hua","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc , ., Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sydney","family":"Ng","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc , ., Los Angeles, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yixin","family":"Yang","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc , ., Menlo Park, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noam","family":"Kirson","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc , ., Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer T","family":"Fine","sequence":"additional","affiliation":[{"name":"Abivax , Boston, MA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,4,22]]},"container-title":["Crohn's &amp; Colitis 360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/advance-article-pdf\/doi\/10.1093\/crocol\/otag035\/68143764\/otag035.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/advance-article-pdf\/doi\/10.1093\/crocol\/otag035\/68143764\/otag035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T17:00:11Z","timestamp":1776963611000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/crohnscolitis360\/advance-article\/doi\/10.1093\/crocol\/otag035\/8661460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,22]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1093\/crocol\/otag035","relation":{},"ISSN":["2631-827X"],"issn-type":[{"value":"2631-827X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,22]]},"article-number":"otag035"}}